Navigation Links
OROS(R) Methylphenidate in Adults with ADHD: New Insights
Date:5/7/2008

ome. Abuse of methylphenidate may lead to dependence. Tell your health care professional if your child has had problems with alcohol or drugs, has had depression, abnormal thoughts or visions, bipolar disorder, seizures, high blood pressure or has had any heart problems or defects. If your child develops abnormal thinking or hallucinations, abnormal, extreme moods and/or excessive activity, or if aggressive behavior or hostility develops or worsens while taking OROS(R) MPH, consult your health care professional. The most common adverse events reported in children receiving up to 54 mg were headache, upper respiratory tract infection and abdominal pain. The most common adverse events reported by adolescents receiving up to 72 mg were headache, accidental injury and insomnia.

Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) is part of Johnson & Johnson, the world's most broadly based producer of healthcare products. J&JPRD is headquartered in Raritan, NJ, and has facilities throughout Asia, Europe and the United States. J&JPRD is leveraging drug discovery and drug development in a variety of therapeutic areas to address unmet medical needs worldwide.

McNeil Pediatrics(TM), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is committed to meeting the needs of pediatric medicine through the development of therapies specifically formulated for children. McNeil Pediatrics(TM) markets OROS(R) methylphenidate HCL for treatment of children and adolescents with ADHD in the US. McNeil Pediatrics(TM) is continuing to explore other new therapies to meet the special needs of children and the pediatric community. Visit http://www.mcneilpediatrics.net/ for more information.

OROS(R) is a registered trademark of ALZA Corporation.

1: Kessler RC et al, Journal of American Occupational Environmental

Medicine 2005

2: Kessler RC, Adler L, Barkley R, et
'/>"/>

SOURCE McNeil Pediatrics(TM), Division of Ortho-McNeil-Janssen
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Commonly used medications associated with impaired physical function in older adults
2. Pennsylvania Governor Rendell Says Enactment of PA ABC Would Help More Than 8,000 Uninsured Adults in Schuylkill County
3. New Book Helps Older Adults Manage Chronic Pain
4. Los Angeles Jewish Home Unveils Auerbach Behavioral Health Center Filling Community Void for Adults Over 55
5. FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults
6. Social form of bullying linked to depression, anxiety in adults
7. Rat study suggests why teens get hooked on cocaine more easily than adults
8. Grocery Manufacturers Association: Canadian Risk Assessment Reaffirms Safety of Bisphenol A (BPA) for Adults and Children
9. Todays Working Adults Face Long Term Care Double Whammy, Says Denise Gott, Spokesperson for LTC Financial Partners, LLC
10. Youth and Adults Throughout Illinois Urge Governor Blagojevich and Congress: Invest Our Tax Dollars Wisely
11. AUDIO from Medialink and Apple Products Research and Education Council: New Research -- Adults Who Eat Apples, Apple Juice Have Healthier Diets and Lower Risk for Metabolic Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Robins & Morton completed a 67,000 SF ... for the New T-Mobile Financial Care Call Center. The ... demolition of the interior systems, replacement of all windows, ... spaces to accommodate employees. , KP Development’s Director ... to develop such a unique building for their customer, ...
(Date:4/1/2015)... 2015 In April, the Science Museum ... raise autism awareness by illuminating Richmond’s historic train station ... one of thousands of businesses, schools and organizations who ... lighting to brighten up the night sky – and ... collaborative effort is the 8th annual awareness campaign spearheaded ...
(Date:4/1/2015)... Royal River Natural Foods, a locally-owned independent natural ... found the amino acid creatine, which athletes typically use to ... pressure. , The report is part of the ... ,” which Royal River Natural Foods publishes each month as ... the latest in nutrition science. Also in the April issue, ...
(Date:4/1/2015)... NTOCC today launches the Knowledge & Resource Center, a ... improve care transitions and positively impact health outcomes. , ... to tools or resources that align with its mission ... through the promotion of public policy, and education and ... the Knowledge & Resource Center serves as a mechanism ...
(Date:4/1/2015)... CA, March 24, 2015 (PRWEB) April 01, 2015 ... by many, the most extreme jungle adventure you could ever ... many as 23 days. Endorsed by the Philippine Department of ... people have visited the rainforest, but very few people have ... Bergman, Chief Adventure Officer. , Armed with nothing more than ...
Breaking Medicine News(10 mins):Health News:Robins & Morton Transforms Former Southern Living Media Services Building for New T-Mobile Financial Care Call Center 2Health News:New Study Finds Strength-Building Supplement Improves Circulation, Retailer Reports 2Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 2Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 3
... of Radiotherapy and Oncology at the Post Graduate Institute ... //Tuesday as National Cancer Awareness Day, organizing a poster ... ,The PGI Director, Dr. K.K. Talwar, stated that this ... the early detection and prevention of cancer. He said, ...
... Hong Kong have been advised to build a three-month stockpile ... of a bird flu pandemic, a news report said Tuesday. ... 60,000 registered US citizens in the former British colony urging ... flu season. ,It suggests stockpiling 4.5 litres of ...
... Diabetics will soon have transformed lives through an artificial ... continuously //as well as provides insulin automatically. This could ... tests and injections. ,Around 350,000 Britons ... raises its head in childhood or young adulthood. ...
... dilemma; whether to preserve the Roman Catholic Church's "traditional ... //policy that gives us an effective weapon against AIDS ... and infallibility to new challenges," according to Peter Boulay, ... ,Cardinal Javier Lozano Barragan in April said ...
... Kong health director Margaret Chan Tuesday emerged as favourite ... Organisation (WHO). // ,The 60-year-old obstetrician, who led ... five-person shortlist of candidates released overnight ahead of a ... got 32 votes in the first round of voting ...
... with smoking have resulted in delayed healing in mice. ... million illnesses //in U.S., having harmful effects on variety ... Smoking. Studies have proved that the toxins contained in ... In addition, smokers are highly prone to hip ...
Cached Medicine News:Health News:Cure of Cancer Requires Early detection 2Health News:Lives of Diabetics Transformed 2Health News:Consequences Of Smoking On Fractures & Ligament Injuries 2
(Date:4/1/2015)... 1, 2015  Hologic, Inc. (NASDAQ: HOLX ) ... 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. ... Company, the trustee, paying agent and conversion agent for ... notes.  This conversion right is subject to the terms ... of December 10, 2007, as supplemented by the second ...
(Date:4/1/2015)... 2015  The first national study to look ... treat attention-deficit/hyperactivity disorder (ADHD) among children ages 4-17 ... with ADHD were receiving behavioral therapy in 2009-2010 ... Prevention (CDC) study, "Treatment of Attention-Deficit/Hyperactivity Disorder among ... in The Journal of Pediatrics provides ...
(Date:4/1/2015)... , April 1, 2015  The fairness of the ... "Company") by Teva Pharmaceutical Industries ("Teva") is being investigated ... law firm.  The investigation focuses on possible breaches of ... Board of Directors of ASPX for agreeing to sell ... Company announced a definitive agreement for Teva to acquire ...
Breaking Medicine Technology:Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2037 are Eligible to Convert 2CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 2CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 3CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 4WeissLaw LLP: Auspex Pharmaceuticals Inc. Acquisition By Teva Pharmaceutical Industries May Not Be In The Best Interest of ASPX Shareholders 2
... Israel--(BUSINESS WIRE)--Jun 14, 2007 - Can-Fite,BioPharma (TASE:CFBI), a ... Exchange, proceeds with the development of its,third drug ... is currently,in clinical trials and CF102, which is ... the EUALR annual congress of,rheumatology in-vitro and in ...
... of SLE,disease at 52 Weeks and demonstrated ... ROCKVILLE, Md., June 14, 2007 /PRNewswire-FirstCall/ -- ... of Phase 2,trial data demonstrating that LymphoStat-B(R) ... was well tolerated and improved quality of ...
Cached Medicine Technology:Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology 2Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 2Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 3Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 4Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 5Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 6Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 7Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 8